首页|Beclin-1与P62在骨质疏松症中的研究进展

Beclin-1与P62在骨质疏松症中的研究进展

扫码查看
骨质疏松症(OP)是一种以全身性骨量丢失、骨微结构破坏为特征的骨骼疾病,根本病因在于由成骨细胞和破骨细胞介导的骨形成与骨吸收动态平衡失调,骨吸收大于骨形成。而自噬对OP的发生、发展起着重要作用,自噬水平的变化是影响骨平衡的关键因素。研究证实,自噬相关分子 Beclin-1、P62 通过不同层面直接调控自噬小体的形成,从而影响OP的发生与发展。该文对Beclin-1、P62 在OP中的表达机制、作用特点及靶向治疗作一概述,为今后OP的防治以及进一步研究提供理论基础。
Research progress in Beclin-1 and P62 in osteoporosis
Osteoporosis(OP)is a bone disease characterized by systemic bone loss and destruction of bone microstructure.The fundamental cause is the imbalance between bone formation and bone resorption mediated by osteoblasts and osteoclasts,and bone resorption is greater than bone formation.Autophagy plays an important role in the occurrence and development of osteoporosis,and the change of autophagy level is a key factor affecting bone balance.Studies have confirmed that autophagy-related molecules of Beclin-1 and P62 directly regulate the formation of autophagosomes at different levels,thus affecting the occurrence and development of OP.In this article,the expression mechanism,functional characteristics and targeted therapy of Beclin-1 and P62 in OP were reviewed,aiming to provide a theoretical basis for the prevention,treatment and subsequent research of OP.

AutophagyOsteoporosisP62Beclin-1Targeted therapy

靳文君、郑琳、罗珊珊、程余婷、巩仔鹏、廖健

展开 >

550001 贵阳,贵州医科大学口腔医学院

550001 贵阳,贵州医科大学附属口腔医院

550004 贵阳,贵州医科大学民族药与中药开发应用教育部工程研究中心

自噬 骨质疏松症 P62 Beclin-1 靶向治疗

2023年贵州省科技厅重点基金

黔科合基础-ZK[2023]重点037

2024

新医学
中山大学

新医学

CSTPCD
影响因子:0.8
ISSN:0253-9802
年,卷(期):2024.55(2)
  • 51